Articles dans des revues avec comité de lecture (128)
70.
Wolff, L., Martiny, D., Miendje Deyi, Y. V., Maillart, E., Clevenbergh, P., & Dauby, N. (2020). COVID-19–Associated Fusobacterium nucleatum Bacteremia, Belgium. Emerging infectious diseases, 27(3). doi:10.3201/eid2703.20228471.
Vermeersch, S., Abreu, A., Dauby, N., Merckx, B., & Bencina, G. (2020). PIN129 Horizon Scanning of Immunisation Budget for Belgium Using an Immunisation Planning Tool. Value in health, 23, S565. doi:10.1016/j.jval.2020.08.97072.
Devos, T., Geukens, T., Schauvlieghe, A., Ariën, K. K., Barbezange, C., Cleeren, M., Compernolle, V., Dauby, N., Desmecht, D., Grimaldi, D., Lambrecht, B., Luyten, A., Maes, P., Moutschen, M., Romano, M., Seyler, L., Toungouz Nevessignsky, M., Vandenberghe, K., Van Griensven, J., Verbeke, G., Vlieghe, E., Yombi, J. C., Liesenborghs, L., Verhamme, P., & Meyfroidt, G. (2020). A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial. Trials, 21(1). doi:10.1186/s13063-020-04876-074.
Thémans, P., Belkhir, L., Dauby, N., Yombi, J.-C., De Greef, J., Delongie, K. A., Vandeputte, M., Nasreddine, R., Wittebole, X., Wuillaume, F., Lescrainier, C., Verlinden, V., Kiridis, S., Dogné, J.-M., Hamdani, J., Wallemacq, P., & Musuamba, F. T. S. F. (2020). Population Pharmacokinetics of Hydroxychloroquine in COVID-19 Patients: Implications for Dose Optimization. European journal of drug metabolism and pharmacokinetics, 45(6), 703-713. doi:10.1007/s13318-020-00648-y75.
Graux, E., Hites, M., Martiny, D., Maillart, E., Delforge, M., Melin, P., & Dauby, N. (2020). Invasive group B Streptococcus among non-pregnant adults in Brussels-Capital Region, 2005–2019. European journal of clinical microbiology & infectious diseases. doi:10.1007/s10096-020-04041-078.
Catteau, L., Dauby, N., Montourcy, M., Bottieau, E., Hautekiet, J., Goetghebeur, E., van Ierssel, S., Duysburgh, E., Van Oyen, H., Wyndham-Thomas, C., Van Beckhoven, D., & Belgian Collaborative Group on COVID-19 Hospital Surveillance, (2020). Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants. International journal of antimicrobial agents, 56(4), 106144. doi:10.1016/j.ijantimicag.2020.10614479.
Subissi, L., Bossuyt, N., Reynders, M., Gerard, M., Dauby, N., Bourgeois, M., Delaere, B., Quoilin, S., Van Gucht, S., Thomas, I., & Barbezange, C. (2020). Capturing respiratory syncytial virus season in Belgium using the influenza severe acute respiratory infection surveillance network, season 2018/19. Eurosurveillance, 25(39). doi:10.2807/1560-7917.ES.2020.25.39.190062780.
Nagant, C., Ponthieux, F., Smet, J., Dauby, N., Doyen, V., Besse-Hammer, T., De Bels, D., Maillart, E., & Corazza, F. (2020). A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer. International journal of infectious diseases. doi:10.1016/j.ijid.2020.10.00381.
Schrooyen, L., Delforge, M.-L., Lebout, F., Vanbaelen, T., Lecompte, A., & Dauby, N. (2020). Homeless people hospitalized with COVID-19 in Brussels. Clinical microbiology and infection. doi:10.1016/j.cmi.2020.08.002